癌症通过禁食让你昏倒:因癌症的代谢变化而导致的白内障
Salvatore Cortellino1,2,3, Margherita D'Angelo4, Massimiliano Quintiliani3
1Laboratory of Molecular Oncology, Responsible Research Hospital, Campobasso, Italy.
Journal of cellular physiology
|September 9, 2024
概括
癌症会导致代谢变化和炎症,导致营养不良和预后不佳. 本综述探讨了这些影响和潜在的干预措施,以改善癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 瘤微环境 瘤微环境
背景情况:
- 新塑性转化改变了瘤和宿主细胞的新陈代谢,增加了营养需求和耗尽.
- 瘤诱导的慢性炎症是一种高能耗的过程,进一步消耗营养.
- 系统性影响包括内分泌,神经和胃肠功能受损,导致营养不良.
研究的目的:
- 探索瘤转变如何影响瘤和微环境新陈代谢和炎症.
- 审查这些变化对患者预后的影响.
- 讨论潜在的策略和临床干预措施,以改善患者的治疗结果.
主要方法:
- 关于瘤转化对新陈代谢和炎症的影响的文献综述.
- 分析瘤微环境中的营养消耗和耗尽.
- 对癌症患者的全身代谢和生理影响的检查.
主要成果:
- 癌细胞重新编程新陈代谢,导致营养物质耗尽.
- 慢性炎症加剧了营养消耗和全身代谢.
- 营养不良是常见的后果,预后恶化和增加不良事件.
结论:
- 代谢重编程和炎症是癌症缓解症和不良结果的关键驱动因素.
- 了解这些机制对于开发有效的干预措施至关重要.
- 准代谢途径和炎症可能会改善患者的生存率和生活质量.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Overview of Protein Metabolism
848
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
848
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334


